Alicia Snow
Physician Assistant · Lakewood, NYNPI 1003213992
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 204 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,447 and has fallen 94.5% since, to $80 in 2025. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $23.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AbbVie$813
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$785
- Otsuka America Pharmaceutical, Inc.$342
- Alkermes, Inc.$293
- Neurocrine Biosciences, Inc.$278
- plus $1K from 15 others
What the payments were for
- Travel & lodging$2736%
- Food & beverage$4,38293%
- Education$712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 16 | $1,016 |
| AbbVie | 58 | $813 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 59 | $785 |
| Otsuka America Pharmaceutical, Inc. | 11 | $342 |
| Alkermes, Inc. | 10 | $293 |
| Neurocrine Biosciences, Inc. | 8 | $278 |
| Gilead | 9 | $274 |
| Indivior Inc. | 5 | $205 |
| Vanda Pharmaceuticals Inc. | 9 | $202 |
| Teva Pharmaceuticals USA, Inc. | 3 | $135 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Sunovion Pharmaceuticals Inc. | 3 | $52 |
| Pfizer | 2 | $37 |
| Braeburn Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Menarini Silicon Biosystems, Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Exeltis, USA Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $15 |
| Corium, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,726 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify AsimtufiiAripiprazole | 11 | $60,030 |
| LybalviOlanzapine/Samidorphan Malate | 25 | $37,024 |
| VraylarCariprazine Hcl | 13 | $26,932 |
| RexultiBrexpiprazole | 12 | $20,369 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 27 | $7,218 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 38 | $5,149 |
| Vilazodone Hcl | 16 | $3,761 |
| Aripiprazole | 31 | $2,635 |
| Duloxetine Hcl | 99 | $2,288 |
| Buspirone Hcl | 52 | $1,520 |
| Bupropion XlBupropion Hcl | 52 | $1,464 |
| Paliperidone ErPaliperidone | 13 | $1,426 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 26 | $1,363 |
| Olanzapine | 40 | $1,208 |
| Zolpidem Tartrate ErZolpidem Tartrate | 15 | $1,198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Asimtufii, Rexulti | $342 | $80,39923 claims |
| Alkermes, Inc.Lybalvi | $293 | $37,02425 claims |
| AbbVieVraylar | $813 | $26,93213 claims |
| Indivior Inc.Suboxone | $205 | $7,21827 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Lakewood
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.